Ansink E. and Wesseler J. (2009), ‘Quantifying type I and type II errors in decision-making under uncertainty: the case of GM crops’, Letters in Spatial and Resource Sciences
Apel A. (2010), ‘The costly benefits of opposing agricultural biotechnology’, New Biotechnology
Arrow K.J. and Fisher A.C. (1974), ‘Environmental preservation, uncertainty, and irreversibility’, Quarterly Journal of Economics
Arrow K., Cropper M., Eads G., et al. (1996), ‘Is there a role for benefit-cost analysis in environmental, health, and safety regulation?’, Science
Batista R., Saibo N., Lourenco T., and Oliveira M. (2008), ‘Microarray analyses reveal that plant mutagenesis may induce more transcriptomic changes than transgene insertion’, Proceedings of the National Academy of Science USA
Baudo M., Lyons R., Powers S., Pastori G., Edwards K., Holdsworth M., and Shewry P. (2006), ‘Transgenesis has less impact on the transcriptome of wheat grain than conventional breeding’, Plant Biotechnology Journal
Bennett A.B., Chi-Ham C., Barrows G., Sexton S., and Zilberman D. (2013), ‘Agricultural biotechnology: economics, environment, ethics, and the future’, Annual Review of Environment and Resources
Billingsley P. (2012), Probability and Measure, Hoboken, NJ: John Wiley.
Case A. and Paxson C. (2006), ‘Stature and status: height, ability, and labor market outcomes’, Journal of Political Economy
Committee on Agriculture (2012), Cultivation of Genetically Modified Food Crops – Prospects and Effects, New Delhi: Lok Sabha Secretariat.
Currie J. and Hyson R. (1999), ‘Is the impact of health shocks cushioned by socioeconomic status? The case of low birth weight’, American Economic Review
Deaton A. (2003), ‘Health, inequality, and economic development’, Journal of Economic Literature
Dixit A. and Pindyck R. (1994), Investment Under Uncertainty, Princeton, NJ: Princeton University Press.
Doblhammer G. and Vaupel J. (2001), ‘Lifespan depends on month of birth’, Proceedings of the National Academy of Sciences USA
Enserink M. (2008), ‘Tough lessons from Golden Rice’, Science
Fogel R.W. (1994), ‘Economic growth, population theory and physiology: the bearing of long-term processes on the making of economic policy’, American Economic Review
Graff G., Hochman G., and Zilberman D. (2009), ‘The political economy of agricultural biotechnology policies’, AgBioForum
Graff G., Hochman G., and Zilberman D. (2013), ‘The political economy of technological regulation in the face of creative destruction: the case of agricultural biotechnology’, in Herring R. (ed.), Oxford Handbook on Food, Politics and Society, Oxford: Oxford University Press.
Greenpeace (2005), Golden Rice: All Glitter, No Gold, Amsterdam: Greenpeace International.
Greenpeace (2012), Golden Illusion: The Broken Promises of ‘Golden’ Rice, Amsterdam: Greenpeace International.
Hennessy D. and Moschini G. (2006), ‘Regulatory actions under adjustment costs and the resolution of scientific uncertainty’, American Journal of Agricultural Economics
Herman R., Chassy B., and Parrott W. (2009), ‘Compositional assessment of transgenic crops: an idea whose time has passed’, Trends in Biotechnology
Herring R. (2007), ‘Opposition to transgenic technologies: ideology, interests and collective action frames’, Nature Review Genetics
Herring R. (2010), ‘Epistemic brokerage in the bio-property narrative: contributions to explaining opposition to transgenic technologies in agriculture’, New Biotechnology
Herring R. (2012), ‘State science and its discontents: why India's second transgenic crop did not follow the path of Bt cotton’, paper presented at the Weihenstephaner Socio-Economic Seminar, Center of Life and Food Sciences Weihenstephan, Technische Universität München, 13 June.
King C.H. and Bertino A.M. (2008), ‘Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases’, PLoS Neglected Tropical Diseases
Kolstad C. (1987), ‘Uniformity versus differentiation in regulating externalities’, Journal of Environmental Economics and Management
Murray C. and Lopez A. (1996), The Global Burden of Disease, Vol. 1, Cambridge, MA: Harvard University Press.
Paarlberg R. (2008), Starved for Science: How Biotechnology is Being Kept Out of Africa, Cambridge, MA: Harvard University Press.
Potrykus I. (2010a), ‘Regulation must be revolutionized’, Nature
Potrykus I. (2010b), ‘Lessons from the “Humanitarian Golden Rice” project: regulation prevents development of public good genetically engineered crop products’, New Biotechnology
Qaim M., Stein A., and Meenakshi J.V. (2007), ‘Economics of biofortification’, Agricultural Economics
Ramessar K., Peremarti A., Gomez-Galera S., Naqvi S., Moralejo M., Munoz P., Capell T., and Chritou P. (2007), ‘Biosafety and risk assessment framework for selectable marker genes in transgenic crop plants: a case of the science not supporting the politics’, Transgenic Research
Richards M., Hardy R., Kuh D., and Wadsworth M. (2002), ‘Birth weight, postnatal growth and cognitive function in a national UK birth cohort’, International Journal of Epidemiology
Shewry P., Baudo M., Lovegrove A., and Powers S. (2007), ‘Are GM and conventionally bred cereals really different?’, Trends in Food Sciences and Technology
Stein A. (2006), Micronutrient Malnutrition and the Impact of Modern Plant Breeding on Public Health in India: How Cost-effective is Biofortification?, Göttingen: Cuvillier Verlag.
Stein A., Sachdev H., and Qaim M. (2008), ‘Genetic engineering for the poor: Golden Rice and public health in India’, World Development
Swinnen J.F.M. and Vandemoortele T. (2010), ‘Policy gridlock or future change? The political economy dynamics of EU biotechnology regulation’, AgBioForum
Tang G., Qin J., Dolnikoawski G., Russell R., and Grusak M. (2009), ‘Golden Rice is an effective source of vitamin A’, American Journal of Clinical Nutrition
Tang G., Hu Y., Yin S., Wang Y., Dallal G., Grusak M., and Russell R. (2012), ‘β-Carotene in Golden Rice is as good as β-carotene in oil at providing vitamin A to children’, American Journal of Clinical Nutrition
Taylor H. and Karlin S. (1984), An Introduction to Stochastic Modeling, Orlando, FL: Academic Press.
Thomas D. and Frankenberg E. (2002), ‘Health, nutrition and prosperity: a microeconomic perspective’, Bulletin of the World Health Organization
van den Belt H. (2003), ‘Debating the precautionary principle: “guilty until proven innocent” or “innocent until proven guilty”?’, Plant Physiology
Vigani M. and Olper A. (2014), ‘GM-free private standards, public regulation of GM products and mass media’, Environment and Development Economics, this issue.
Wesseler J. (2009), ‘The Santaniello theorem of irreversible benefits’, AgBioForum
Wesseler J., Scatasta S., and Fall E. (2011), ‘Environmental benefits and costs of GM crops’, in Carter C., Moschini G.C., and Sheldon I. (eds), Genetically Modified Food and Global Welfare, Bingley: Emerald Group Publishing, pp. 173–199.
Wesseler J., Leimgruber S., and Smart R. (2012), ‘Comparison of time periods in the approval processes for GM crops in the EU, USA, Canada & South Africa’, Paper presented at the 16th ICABR Conference, 128th EAAE Seminar, Ravello, Italy, 24–27 June.
West K. and Darnton-Hill I. (2008), ‘Vitamin A deficiency’, in Semba R.D. and Bloem M.W. (eds), Nutrition and Health in Developing Countries, Totowa, NJ: Humana Press, pp. 377–433.
World Health Organization (2001), Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health, Geneva: World Health Organization.
Zimmermann R. and Qaim M. (2004), ‘Potential health benefits of Golden Rice: a Philippine case study’, Food Policy